• American Academy of Pediatrics (AAP) (2012). Red Book: 2012 Report of the Committee on Infectious iseases. Pickering LK, ed. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics.
• Van Howe RS, Kusnier LP. Diagnosis and management of pharyngitis in a pediatric population based on cost-effectiveness and projected health outcomes. Pediatrics 2006; 117: 609-19.
• Bisno AL, Gerber MA, Gwaltney JM , Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002;35:113–25.
• Institute for Clinical Systems Improvement (ICSI). Health Care Guideline: Diagnosis and Treatment of Respiratory Illness in Children and Adults. First Edition. Bloomington, MN: Institute for Clinical Systems Improvement.
• Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Beneden CV (2012). Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. IDSA Guideline for GAS Pharyngitis CID 2007; pp 1-17.
• Brundage JF, Gunzenhauser JD, Longfield JN, et al. Epidemiology and control of acute respiratory disease with emphasis on group A beta-hemolytic Streptococcus: a decade of U.S. Army experience. Pediatrics 1996; 97: 964–70.
• Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 18th informational supplement. CLSI/NCCLS M100-S18. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania 2008.
• WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease. Rheumatic fever and rheumatic heart disease: report of a WHO Expert Consultation, 29 October - 1 November 2001. Geneva 2004.
• Nordet P, Lopez R, Dueñas A, Sarmiento L. Prevention and control of rheumatic fever and rheumatic heart disease: the Cuban experience (1986–1996–2002). Cardiovasc J Africa 2008;19: 135-40.
• Santos O, Weckx LLM, Pignatari ACC, Pignatari SSN. Detection of group A beta-hemolytic Streptococcus employing three different detection methods: Culture, rapid antigen detecting test, and molecular assay. BJID 2003; 7: 297-300.
• Omurzakova NA, Yamano Y, Saatova GM, Alybaeva MS, Nishioka K, Nakajima T. Prevalence of group A β-hemolytic Streptococcus among children with tonsillopharyngitis in Kyrgyzstan: The difficulty of diagnostics and therapy. Open Rheumatol J 2010;4: 39-46.
• Morais VMS, Orsi AR, Maranhão FCA, Castro TMPPG, Castro KCB, Silva DMW. Prevalence of β-hemolytic Streptococcus in children with special health care needs. Braz J Otorhinolaryngol 2012; 78:110-5.
• Martin JM, Green M, Barbadora KA, Wald ER. Group A Streptococci among school-aged children: Clinical characteristics and the carrier state. Pediatrics 2004;114:1212-9.
• Danchin MH, Rogers S, Selvaraj G, et al. The burden of group A streptococcal pharyngitis in Melbourne families. Indian J Med Res 2004;119: 144-7.
• Doğan M, Feyzioğlu B, Çimen Ö, et al. Investigation of antibiotic susceptibility for group A β-hemolytic Streptococci which isolated at tonsillar swab samples of 5-15 years old children. XXXIII. Turkish Microbiology Congress, Congress book; Bodrum, 2008; pp 652.
• Haczyński J, Chmielik M, Bardadin J, et al. A comparative study of cefaclor vs amoxicillin/clavulanate in tonsillopharyngitis. Med Sci Monit 2003;9: 29-35.
• Özakkafi F, Aksungar FB, Topkaya AE. Examination of antibiotic susceptibility of group A Beta-hemolytic Streptococci. ANKEM J 2007; 21: 10-3 (in Turkish).
• Eryilmaz M, Akin A, Akan OA. The antibiotic susceptibilities of group A beta-hemolytic Streptococci isolated from throat cultures. ANKEM J 2006; 20:10-2(in Turkish).
• İnan N, Erdoğan H, Berkiten R. Grouping and antibiotic resistance of beta-hemolytic Streptococci isolated from various clinical samples. Klimik J 2003;16: 118-120(in Turkish).

Vancouver

Doğan M, Aydemir Ö, Güner ŞN, Feyzioğlu B, Baykan M. Antibiotic Susceptibility of Group A Β-Hemolytic Streptococci Isolated From Tonsillar Swab Samples in 5-15 Years Old Children. EUR J GEN MED. 2014;11(1):29-32. https://doi.org/10.15197/sabad.1.11.07

APA

Doğan, M., Aydemir, Ö., Güner, Ş. N., Feyzioğlu, B., & Baykan, M. (2014). Antibiotic Susceptibility of Group A Β-Hemolytic Streptococci Isolated From Tonsillar Swab Samples in 5-15 Years Old Children. European Journal of General Medicine, 11(1), 29-32. https://doi.org/10.15197/sabad.1.11.07

AMA

Doğan M, Aydemir Ö, Güner ŞN, Feyzioğlu B, Baykan M. Antibiotic Susceptibility of Group A Β-Hemolytic Streptococci Isolated From Tonsillar Swab Samples in 5-15 Years Old Children. EUR J GEN MED. 2014;11(1), 29-32. https://doi.org/10.15197/sabad.1.11.07

Chicago

Doğan, Metin, Özlem Aydemir, Şükrü Nail Güner, Bahadır Feyzioğlu, and Mahmut Baykan. "Antibiotic Susceptibility of Group A Β-Hemolytic Streptococci Isolated From Tonsillar Swab Samples in 5-15 Years Old Children". European Journal of General Medicine 2014 11 no. 1 (2014): 29-32. https://doi.org/10.15197/sabad.1.11.07

Harvard

Doğan, M., Aydemir, Ö., Güner, Ş. N., Feyzioğlu, B., and Baykan, M. (2014). Antibiotic Susceptibility of Group A Β-Hemolytic Streptococci Isolated From Tonsillar Swab Samples in 5-15 Years Old Children. European Journal of General Medicine, 11(1), pp. 29-32. https://doi.org/10.15197/sabad.1.11.07

MLA

Doğan, Metin et al. "Antibiotic Susceptibility of Group A Β-Hemolytic Streptococci Isolated From Tonsillar Swab Samples in 5-15 Years Old Children". European Journal of General Medicine, vol. 11, no. 1, 2014, pp. 29-32. https://doi.org/10.15197/sabad.1.11.07